Henan Taloph Pharmaceutical Stock Co Ltd (600222) — Cash Flow Reinvestment Rate
Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Cash Flow Reinvestment Rate of 0.24x as of September 2025, reinvesting CN¥5.45 Million (capex CN¥5.45 Million ) from operating cash flow of CN¥22.69 Million. See 600222 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Henan Taloph Pharmaceutical Stock Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see 600222 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)
Year-by-year capital reinvestment analysis for Henan Taloph Pharmaceutical Stock Co Ltd. See Henan Taloph Pharmaceutical Stock Co Ltd (600222) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.90x | CN¥42.25 Million | CN¥47.16 Million | CN¥21.12 Million | ▼ -74.2% |
| 2023 | 3.48x | CN¥152.04 Million | CN¥43.74 Million | CN¥43.13 Million | ▲ +173.3% |
| 2021 | 1.27x | CN¥126.74 Million | CN¥99.66 Million | CN¥39.07 Million | ▼ -51.6% |
| 2020 | 2.63x | CN¥192.82 Million | CN¥73.43 Million | CN¥72.65 Million | ▼ -31.7% |
| 2019 | 3.84x | CN¥159.55 Million | CN¥41.53 Million | CN¥107.68 Million | ▲ +378.1% |
| 2018 | 0.80x | CN¥96.01 Million | CN¥119.47 Million | CN¥66.41 Million | ▼ -87.2% |
| 2017 | 6.27x | CN¥145.19 Million | CN¥23.17 Million | CN¥44.34 Million | ▲ +484.4% |
| 2016 | 1.07x | CN¥75.70 Million | CN¥70.60 Million | CN¥59.60 Million | ▼ -48.6% |
| 2015 | 2.08x | CN¥102.71 Million | CN¥49.27 Million | CN¥62.04 Million | ▲ +424.0% |
| 2014 | 0.40x | CN¥35.62 Million | CN¥89.54 Million | CN¥35.62 Million | ▲ +133.4% |
| 2012 | 0.17x | CN¥14.91 Million | CN¥87.45 Million | CN¥14.91 Million | ▼ -100.0% |
| 2011 | 612.28x | CN¥64.41 Million | CN¥105.20K | CN¥64.41 Million | ▲ +46377.1% |
| 2009 | 1.32x | CN¥28.25 Million | CN¥21.45 Million | CN¥28.25 Million | ▼ -41.7% |
| 2008 | 2.26x | CN¥40.98 Million | CN¥18.13 Million | CN¥40.98 Million | ▲ +13.7% |
| 2007 | 1.99x | CN¥42.42 Million | CN¥21.34 Million | CN¥42.42 Million | ▼ -91.4% |
| 2006 | 22.99x | CN¥36.64 Million | CN¥1.59 Million | CN¥36.64 Million | ▼ -69.0% |
| 2005 | 74.04x | CN¥20.46 Million | CN¥276.30K | CN¥20.46 Million | ▲ +8971.7% |
| 2004 | 0.82x | CN¥14.90 Million | CN¥18.25 Million | CN¥14.90 Million | ▼ -81.9% |
| 2003 | 4.52x | CN¥16.89 Million | CN¥3.74 Million | CN¥16.89 Million | ▲ +430.5% |
| 2002 | 0.85x | CN¥6.36 Million | CN¥7.47 Million | CN¥6.36 Million | ▼ -20.2% |
| 2001 | 1.07x | CN¥58.73 Million | CN¥55.03 Million | CN¥58.73 Million | ▼ -99.1% |
| 2000 | 123.50x | CN¥108.11 Million | CN¥875.36K | CN¥108.11 Million | ▲ +15260.6% |
| 1999 | 0.80x | CN¥79.86 Million | CN¥99.32 Million | CN¥79.86 Million | ▲ +63076.1% |
| 1998 | 0.00x | CN¥35.69K | CN¥28.04 Million | CN¥35.69K | — |